Plasma levels of soluble programmed death ligand-1 may be associated with overall survival in nonsmall cell lung cancer patients receiving thoracic radiotherapy

Immune-checkpoint signaling plays an important role in immunosuppression of tumors. We aimed to investigate the association of soluble programmed death-ligand 1 (sPD-L1) level in plasma with overall survival (OS) in locally advanced or inoperable nonsmall-cell lung cancer (NSCLC) patients treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jing, Zhang, Peng, Wang, Jianhua, Xi, Qingsong, Zhao, Xueqi, Ji, Minghua, Hu, Guangyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319514/
https://www.ncbi.nlm.nih.gov/pubmed/28207525
http://dx.doi.org/10.1097/MD.0000000000006102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319514/
https://www.ncbi.nlm.nih.gov/pubmed/28207525
http://dx.doi.org/10.1097/MD.0000000000006102

Ejemplares similares